Medicinal product with the active substance Secukinumab (ATC: L04AC10)
Arzneimittel mit dem Wirkstoff Secukinumab (ATC: L04AC10)
Germany · Magdeburg · how to bid here →
Your path to submission
- Deadline: 29 November at 22:00 — 54 days left.
- You submit on Vergabemarktplatz (cosinex) — not here and not by e-mail. ↗ Free bidder account on the cosinex platform required (created instantly); offers go through the bidding tool, usually plain text form suffices — no qualified signature. Sort out account and signature first — not on submission day.
- Offer and evidence in: DEU.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 4 months (36 awards, most recently September 2026) — the next award is due around January 2027 by that rhythm. The last award went to Novo Nordisk Pharma GmbH.n = 36
- 49% of this buyer's awards went to companies that had already won here before (103 awards since 2018, spread over 53 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 103 awards since 2018
- The median procedure drew just one bid (99 procedures with a bid count); 60% ended with a single bidder. Sector: median 2 bids.n = 99
- Across 119 procedures with structured selection criteria, this buyer most often required: Trade register enrolment (118 of 119), Quality management (2 of 119), References: services (2 of 119), Professional liability insurance (2 of 119).n = 119
- Not one of the 103 awards with a known winner country has gone to a foreign company so far. Sector average: 1%.n = 103
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 265 contracts went to foreign companies over the last 3 years (of 22,200 recorded awards) — mostly from Austria, Netherlands, France.
Typical field: median 1 (from 106 awards).
What the buyer is looking for
The subject of this publication is the conclusion of non-exclusive discount agreements pursuant to § 130a(8) SGB V for finished medicinal products with the active substance secukinumab (ATC: L04AC10) as part of a so-called "open-house model". Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement pursuant to § 130a(8) SGB V on the above-mentioned active substances or medicinal products. Interested pharmaceutical companies can request the participation documents and the respective contract from the aforementioned contact address. The prerequisite for the conclusion of a contract is that the interested pharmaceutical company completes and signs the requested participation documents in full. Description of the…
Show full description
… procurement (type and scope of the service or indication of needs and requirements) Conclusion of non-exclusive discount agreements pursuant to § 130a(8) SGB V for finished medicinal products with the active substance secukinumab (ATC: L04AC10) at any time in the context of a so-called "open-house model". A contract is concluded with each pharmaceutical company that meets the requirements for participation.
What you must prove — eligibility criteria
From the notice of the same procedure on TED — Tenders Electronic Daily.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Novartis Pharma GmbH · Nürnberg | 7 | 2013–2026 |
| PIK AG | 5 | 2025 |
| Bayer Vital GmbH · Leverkusen | 5 | 2014–2026 |
| GlaxoSmithKline GmbH & Co. KG · München | 5 | 2012–2026 |
| Pfizer Pharma GmbH · Berlin | 5 | 2023–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.
How to bid
Guide: how to apply on cosinex Vergabemarktplatz / DTVP → Registration, signature, fees — from the operator's bidder manual.